Estimating the prevalence of agitation in community-dwelling persons with Alzheimer's disease

被引:36
|
作者
Tractenberg, RE
Weiner, ME
Thal, LJ
机构
[1] Univ Calif San Diego, Alzheimers Dis Cooperat Study, Dept Neurosci, La Jolla, CA 92093 USA
[2] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA
关键词
D O I
10.1176/appi.neuropsych.14.1.11
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To estimate the prevalence of, and develop norms for, significant agitation in community-dwelling persons with Alzheimer's disease (AD), the authors applied three different criteria to persons with AD (n=235) and normal elderly control subjects (NEC; n = 64). The criteria were used to identify the minimum total score on the Cohen-Mansfield Agitation Inventory (CMAI) that represents significant or "excessive" agitation and to estimate its prevalence. The "ultraliberal" criterion resulted in 99.1% of persons with AD and 56.6% of NEC being classified as "excessively" disturbed. The "liberal" and "conservative" criteria classified 66.7% and 68.2% of persons with AD, and no NEC, as "excessively" disturbed. The authors conclude that the best estimate of prevalence of excessive agitation in this population is 67.5%, and that individuals with CMAI scores of 0 to 14 probably should not be considered to have excessive agitation.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [21] Oxcarbazepine in the management of behavioral agitation in community-dwelling patients with Alzheimer's disease: An open-label study
    Shua-Haim, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S434 - S434
  • [22] Long-Term Use of Opioids Among Community-Dwelling Persons with and without Alzheimer's Disease
    Hamina, Aleksi
    Taipale, Heidi
    Tanskanen, Antti
    Tolppanen, Anna-Maija
    Tiihonen, Jari
    Hartikainen, Sirpa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 369 - 369
  • [23] Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease
    Koponen, Marjaana
    Taipale, Heidi
    Lavikainen, Piia
    Tanskanen, Antti
    Tiihonen, Jari
    Tolppanen, Anna-Maija
    Ahonen, Riitta
    Hartikainen, Sirpa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 363 - 363
  • [24] Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease
    Torvinen-Kiiskinen, Sanna
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    Taipale, Heidi
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (12) : E107 - E115
  • [25] Risk of Pneumonia Associated with Incident Benzodiazepine Use Among Community-Dwelling Persons with Alzheimer's Disease
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Koponen, Marjaana
    Tanskanen, Antti
    Lavikainen, Piia
    Sund, Reijo
    Tiihonen, Jari
    Hartikainen, Sirpa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 367 - 367
  • [26] Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease
    Tiihonen, Miia
    Taipale, Heidi
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 (01) : 127 - 132
  • [27] Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease
    Koponen, Marjaana
    Taipale, Heidi
    Lavikainen, Piia
    Tanskanen, Antti
    Tiihonen, Jari
    Tolppanen, Anna-Maija
    Ahonen, Riitta
    Hartikainen, Sirpa
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 56 (01) : 107 - 118
  • [28] Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease
    Kettunen, Reetta
    Taipale, Heidi
    Tolppanen, Anna-Maija
    Tanskanen, Antti
    Tiihonen, Jari
    Hartikainen, Sirpa
    Koponen, Marjaana
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (03) : 417 - 425
  • [29] Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
    Reetta Kettunen
    Heidi Taipale
    Anna-Maija Tolppanen
    Antti Tanskanen
    Jari Tiihonen
    Sirpa Hartikainen
    Marjaana Koponen
    European Journal of Clinical Pharmacology, 2019, 75 : 417 - 425
  • [30] Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study
    Laitinen, Marja-Liisa
    Lonnroos, Eija
    Bell, J. Simon
    Lavikainen, Piia
    Sulkava, Raimo
    Hartikainen, Sirpa
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (04) : 669 - 672